Richter's Syndrome! One pill, Triple Combination Therapy is in clinical trial for Richter’s Transformation and De Novo Large B-Cell Lymphoma with impressive results. In this ASH 2020 In this video Dr. Mato tells us that his clinical trial introduces the concept of “synthetic lethality,” where multiple targeted agents are used at low dosages to block different pathways and achieve the ability to kill cancer cells without the associated toxicities of putting three drugs together at the usual dosages. cllsociety.org/2021/01/ash-...
Richter's Syndrome! One pill, Triple Combinati... - CLL Support
Richter's Syndrome! One pill, Triple Combination Therapy is in clinical trial for Richter’s Transformation & De Novo Large B-Cell Lymphoma
Written by
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
5 Replies
•
Jm954Administrator
Great news and, at last, something innovative and hopeful
Very interesting, thanks.
Do you think that the "synthetic lethality" approach could be the way forward for treating blood cancers generally? An effective drug combination with mild side effects, taken as a single tablet, has to be the CLL patient's dream.
Thank you for sharing!
Not what you're looking for?
You may also like...
Off ibrutinib x 2 weeks, a novel ultra low dose triple therapy for CLL and Richter's and CLL Society recognized for its reliable robust info
How about no COVID-19 news in a post:
I updated my blog with good news at...
Dr. Fauci shares his recommendation that immunosuppressed patients with blood cancers, like us, get the vaccine, because some immunity is be
ASH 2020 Day 1 Update: ASH 2020 officially started early Saturday Dec. 5th with a fireside chat...
ASH 2019: A Clinical Trial of Cannabis As Targeted Therapy for Indolent Leukemic Lymphoma
"Conclusion:
This study demonstrates that it is safe to administrate a single dose of Sativex to...
Aggressive CLL - Richter's Transformation
Hi Everyone,
My father was diagnosed with aggressive CLL with PLL (prolymphocytic leukemia--where...
YABTKi or Yet Another BTK inhibitor - an A to Z list of Bruton's Tyrosine Kinase Inhibitors and Degraders following ibrutinib's success
I'll admit that YABTKi is not a recognised CLL related acronym, (acronym lists are here...